291 related articles for article (PubMed ID: 21816922)
1. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.
Conkrite K; Sundby M; Mukai S; Thomson JM; Mu D; Hammond SM; MacPherson D
Genes Dev; 2011 Aug; 25(16):1734-45. PubMed ID: 21816922
[TBL] [Abstract][Full Text] [Related]
2. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.
Simpson DS; Mason-Richie NA; Gettler CA; Wikenheiser-Brokamp KA
Cancer Res; 2009 Nov; 69(22):8733-41. PubMed ID: 19887614
[TBL] [Abstract][Full Text] [Related]
5. Compensation by tumor suppressor genes during retinal development in mice and humans.
Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA
BMC Biol; 2006 May; 4():14. PubMed ID: 16672052
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.
Chen D; Livne-bar I; Vanderluit JL; Slack RS; Agochiya M; Bremner R
Cancer Cell; 2004 Jun; 5(6):539-51. PubMed ID: 15193257
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific effects of Rb deletion in the murine retina.
MacPherson D; Sage J; Kim T; Ho D; McLaughlin ME; Jacks T
Genes Dev; 2004 Jul; 18(14):1681-94. PubMed ID: 15231717
[TBL] [Abstract][Full Text] [Related]
8. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
[TBL] [Abstract][Full Text] [Related]
9. p107 is a suppressor of retinoblastoma development in pRb-deficient mice.
Robanus-Maandag E; Dekker M; van der Valk M; Carrozza ML; Jeanny JC; Dannenberg JH; Berns A; te Riele H
Genes Dev; 1998 Jun; 12(11):1599-609. PubMed ID: 9620848
[TBL] [Abstract][Full Text] [Related]
10. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
[TBL] [Abstract][Full Text] [Related]
11. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
[TBL] [Abstract][Full Text] [Related]
12. miR than meets the eye.
Sage J; Ventura A
Genes Dev; 2011 Aug; 25(16):1663-7. PubMed ID: 21852531
[TBL] [Abstract][Full Text] [Related]
13. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.
Nittner D; Lambertz I; Clermont F; Mestdagh P; Köhler C; Nielsen SJ; Jochemsen A; Speleman F; Vandesompele J; Dyer MA; Schramm A; Schulte JH; Marine JC
Nat Cell Biol; 2012 Sep; 14(9):958-65. PubMed ID: 22864477
[TBL] [Abstract][Full Text] [Related]
15. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor.
Tomosugi M; Sowa Y; Yasuda S; Tanaka R; te Riele H; Ikawa H; Koyama M; Sakai T
Cancer Sci; 2012 Dec; 103(12):2139-43. PubMed ID: 22957647
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
[TBL] [Abstract][Full Text] [Related]
20. Rb and p107 are required for alpha cell survival, beta cell cycle control and glucagon-like peptide-1 action.
Cai EP; Luk CT; Wu X; Schroer SA; Shi SY; Sivasubramaniyam T; Brunt JJ; Zacksenhaus E; Woo M
Diabetologia; 2014 Dec; 57(12):2555-65. PubMed ID: 25249236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
